AKT1 and non-small cell lung carcinoma: Shi et al.61 found that cancer-associated fibroblast-derived exosomal microRNA-20a inhibits the PTEN/PI3K-AKT pathway, thereby promoting cancer progression and chemotherapy resistance in non-small cell lung cancer.